G protein-linked signaling pathways in bipolar and major depressive disorders

Hiroaki Tomita, Mary E. Ziegler, Helen B. Kim, Simon J. Evans, Prabhakara V Choudary, Jun Z. Li, Fan Meng, Manhong Dai, Richard M. Myers, Charles R. Neal, Terry P. Speed, Jack D. Barchas, Alan F. Schatzberg, Stanley J. Watson, Huda Akil, Edward G. Jones, William E. Bunney, Marquis P. Vawter

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

The G-protein linked signaling system (GPLS) comprises a large number of G-proteins, G protein-coupled receptors (GPCRs), GPCR ligands, and downstream effector molecules. G-proteins interact with both GPCRs and downstream effectors such as cyclic adenosine monophosphate (cAMP), phosphatidylinositols, and ion channels. The GPLS is implicated in the pathophysiology and pharmacology of both major depressive disorder (MDD) and bipolar disorder (BPD). This study evaluated whether GPLS is altered at the transcript level. The gene expression in the dorsolateral prefrontal (DLPFC) and anterior cingulate (ACC) were compared from MDD, BPD, and control subjects using Affymetrix Gene Chips and real time quantitative PCR. High quality brain tissue was used in the study to control for confounding effects of agonal events, tissue pH, RNA integrity, gender, and age. GPLS signaling transcripts were altered especially in the ACC of BPD and MDD subjects. Transcript levels of molecules which repress cAMP activity were increased in BPD and decreased in MDD. Two orphan GPCRs, GPRC5B and GPR37, showed significantly decreased expression levels in MDD, and significantly increased expression levels in BPD. Our results suggest opposite changes in BPD and MDD in the GPLS, "activated" cAMP signaling activity in BPD and "blunted" cAMP signaling activity in MDD. GPRC5B and GPR37 both appear to have behavioral effects, and are also candidate genes for neurodegenerative disorders. In the context of the opposite changes observed in BPD and MDD, these GPCRs warrant further study of their brain effects.

Original languageEnglish (US)
Article number00297
JournalFrontiers in Genetics
Volume4
Issue numberDEC
DOIs
StatePublished - 2013

Keywords

  • Bipolar disorder
  • Cyclic AMP
  • G-protein coupled receptor (GPCR)
  • GPR37
  • GPRC5B
  • Major depressive disorder
  • Phosphatidylinositol
  • Transcriptome

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'G protein-linked signaling pathways in bipolar and major depressive disorders'. Together they form a unique fingerprint.

  • Cite this

    Tomita, H., Ziegler, M. E., Kim, H. B., Evans, S. J., Choudary, P. V., Li, J. Z., Meng, F., Dai, M., Myers, R. M., Neal, C. R., Speed, T. P., Barchas, J. D., Schatzberg, A. F., Watson, S. J., Akil, H., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2013). G protein-linked signaling pathways in bipolar and major depressive disorders. Frontiers in Genetics, 4(DEC), [00297]. https://doi.org/10.3389/fgene.2013.00297